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Abstract
Background: Retransfusion of the patient's own blood during surgery is used to reduce the need
for allogenic blood transfusion. It has however been found that this blood contains lipid particles,
which form emboli in different organs if the blood is retransfused on the arterial side. In this study,
we tested whether retransfusion of blood containing lipid micro-particles on the venous side in a
porcine model will give hemodynamic effects.
Methods: Seven adult pigs were used. A shed blood surrogate containing 400 ml diluted blood and
5 ml radioactive triolein was produced to generate a lipid embolic load. The shed blood surrogate
was rapidly (<2 minutes) retransfused from a transfusion bag to the right atrium under general
anesthesia. The animals' arterial, pulmonary, right and left atrial pressure were monitored, together
with cardiac output and deadspace. At the end of the experiment, an increase in cardiac output and
pulmonary pressure was pharmacologically induced to try to flush out lipid particles from the lungs.
Results: A more than 30-fold increase in pulmonary vascular resistance was observed, with
subsequent increase in pulmonary artery pressure, and decrease in cardiac output and arterial
pressure. This response was transient, but was followed by a smaller, persistent increase in
pulmonary vascular resistance. Only a small portion of the infused triolein passed the lungs, and
only a small fraction could be recirculated by increasing cardiac output and pulmonary pressure.
Conclusion: Infusion of blood containing lipid micro-emboli on the venous side leads to acute,
severe hemodynamic responses that can be life threatening. Lipid particles will be trapped in the
lungs, leading to persistent effects on the pulmonary vascular resistance.
Background
Autotransfusion of blood is used in surgical procedures to
reduce the need for allogenic blood transfusion. The main
reasons for doing this are to reduce costs and transfusion-
related morbidity. Adverse effects of heterologous transfu-
sions have recently been highlighted [1]. For example, it
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has been shown in cardiac surgery that heterologous
blood transfusion may have negative effects on long-term
survival [2,3].
In addition to autotransfusion, blood conservation strate-
gies are employed routinely in several surgical procedures.
In cardiac surgery, for example, blood lost in the pericar-
dium or pleurae is routinely retransfused directly to the
patient via the heart-lung machine. Sometimes, a centrif-
ugal-based cell-washing procedure is used.
However, autologous transfusions in conjunction with
surgery have raised some controversy, especially after the
finding that this blood contains lipid particles [4-10].
Lipid particles have been found as emboli in many
organs, including the brain and kidneys, after arterial
retransfusion [6,11]. It has been suggested that lipid
emboli contribute to organ dysfunction after surgery
[12,13]. However, present methods of removing these
emboli, such as filters and centrifuges, only seem to
reduce the embolic load to a limited degree [4,8,13,14],
and no safe and truly efficient way of removing these lipid
particles before retransfusing shed blood is available. It
has been suggested that one way of dealing with the prob-
lem could be to transfuse shed blood on the venous side,
utilizing a postulated filtering effect of the lungs.
Several groups have studied the pathologic effect of large
lipid emboli in the venous circulation in conjunction with
orthopedic surgery, and found adverse hemodynamic and
respiratory effects [15-17]. However, little is known about
the effect that numerous lipid micro-emboli, as found in
shed blood collected from the pericardium during cardiac
surgery, may have on the pulmonary circulation.
In this study we investigated the effect of re-transfusion of
blood containing lipid micro-emboli on the venous side,
in terms of hemodynamic and respiratory effects, as well




After approval from the regional animal study ethics com-
mittee, 7 adult pigs were prepared. The animals (70 kg)
were anesthetized and mechanically ventilated. When the
animals showed circulatory stability, a 10 minute resting
period without any activity or stimulation was instituted.
After this period, a shed blood surrogate containing lipid
micro-emboli was infused according to the protocol illus-
trated in Figure 1. The animals were monitored for the fol-
lowing three hours, after which cardiac output and
pulmonary pressure were increased by infusing 200 μg of
epinephrine (Adrenaline Merck NM, Merck NM, Stock-
holm, Sweden) together with 500 ml Ringer's lactate (Fre-
senius Kabi, Uppsala, Sweden).
Monitoring
Catheters for monitoring, drug delivery and blood sam-
pling were inserted into a vein in one of the ears, the jug-
ular internal vein, the left and right atrium, the pulmonary
artery and the femoral and carotid arteries. During the
experiment, arterial and pulmonary blood pressure, cen-
tral venous and left atrium pressure, pulse, nasopharyn-
geal temperature, ventilator settings and pulse oximetry
were monitored continuously with a SpaceLabs Medical
monitoring system (SpaceLabs, Issaquah, WA, USA). Car-
diac output was recorded with a Transonic HT207 ultra-
sonic flow meter (Transonic System Inc., Ithaca, New
York, USA) or a Cardiomed CM 4000 transit time ultra-
sound flow meter (Cardiomed, Toronto, Canada). A 14
mm or 16 mm probe was used to measure the cardiac out-
put in the pulmonary artery. Complete monitoring data
were obtained from all animals except one. The record-
ings of pulmonary artery pressure in one animal were
unstable due to deficient contact between the ultrasonic
transducer and the pulmonary artery, and this pressure
was excluded from the analysis.
Anesthesia
Premedication was performed with an intramuscular
injection of 15 mg/kg ketamine chloride (Ketalar®, Pfizer
Inc., New York, NY, USA) and 0.2 mg/kg xylasine
(Rompun®, Bayer, Gothenburg, Sweden). Induction and
The protocol used for determining physiological response Figure 1
The protocol used for determining physiological 
response. The vertical dashed lines indicate the infusion of 
the shed blood surrogate, and the infusion of epinephrine 
and Ringer's lactate. A denotes the Area Under the Curve 
(AUC) as a measure of decline in blood pressure over time. 
B denotes the AUC indicating blood pressure increase. C 
denotes the increase in blood pressure after the period of 
increased blood pressure and flow induced with epinephrine 
and Ringer's lactate.Journal of Cardiothoracic Surgery 2009, 4:48 http://www.cardiothoracicsurgery.org/content/4/1/48
Page 3 of 9
(page number not for citation purposes)
maintenance of anesthesia were achieved using an infu-
sion of 0.15 mg/kg/min ketamine chloride and 0.01 mg/
kg/min pancuronium bromide (Pavulon®, N.V. Organon,
Oss, the Netherlands), or an infusion of 0.1-0.2 mg/kg/
min propofol (Diprivan®, Astra-Zeneca, Sweden),
together with intermittent injections of fentanyl (Lep-
tanal®, Lilly, France) and atracrium besylate (Tracrium®,
Glaxo, Täby, Sweden). The different anaesthetic protocols
were due to a change in laboratory practice for other rea-
sons, and not related to this study.
The animals underwent tracheostomy and were con-
nected to a ventilator (Siemens Servo 900C, Solna, Swe-
den). Volume controlled ventilation was applied with
50% FiO2. Arterial blood was drawn for blood gas sam-
pling at the start of the study, immediately before admin-
istration of radiolabelled triolein, 5, 15, 30 and 45
minutes thereafter, and immediately before the period of
increased pressure, and 5, 15, 30 and 45 minutes thereaf-
ter. Exhaled gases were monitored continuously with a
NiCO or CO2SMO Plus respiratory profile meter
(Novametrix Medical Systems Inc., Norwell, MA, USA).
The dead space was calculated using the Bohr equation
principle from blood gases and exhaled CO2 [18].
Experimental procedure
A sternotomy was performed to expose the heart and 400
IU/kg heparin (LEO Pharma A/S, Copenhagen, Denmark)
was administered before starting the experiment. At the
end of the experiment the animals were sacrificed using
potassium chloride (B. Braun, Melsungen, Germany) and
thiopental sodium (Pentothal®, Abbot, Chicago, IL, USA).
Administration of radiolabelled triolein
Radioactive triolein (Amersham BioSciences, Little Chal-
font, UK) was mixed with 65% non-radioactive triolein
solution (Carl Roth GmbH., Karlsruhe, Germany). The
proportions used were such that 5 ml of the final solution
contained 1 mCi of radioactivity.
A shed blood surrogate was then produced by mixing 200
ml arterial blood with 200 ml saline and 5 ml of the 1 mCi
radioactive triolein solution. This will yield approxi-
mately 1% lipid content, and has been used in similar
studies [6,19]. The surrogate was gently agitated for
approximately five minutes and retransfused from a pres-
surized transfusion bag with a 40-micron filter in the infu-
sion aggregate, into the animal via the venous line during
a 2-minute period.
Blood sampling
Blood samples for the determination of radioactivity were
drawn from a separate catheter in the carotid artery at
baseline, at the start of infusion of the shed blood surro-
gate, every minute for fifteen minutes and then every ten
minutes up to 3 hours after infusion.
When the infusion of adrenaline and 500 ml Ringer's lac-
tate was started, blood was sampled at the start of infu-
sion, every minute for fifteen minutes and then every ten
minutes up to one hour after the infusion. On each occa-
sion 0.2 ml blood was collected for the determination of
radioactivity.
Sample preparation
To each sample of blood, 2 ml Soulene-350® (Packard Bio-
science, Groningen, the Netherlands) was added to dis-
solve the cells. The sample was left in an air heater at 37°C
overnight. To decolorize the samples, 0.2 ml hydrogen
peroxide was added twice, with overnight incubation at
37°C between. One ml 95% ethanol was added, followed
by 15 ml scintillation fluid (Hionic Fluor, Packard Bio-
science, Groningen, the Netherlands) [6]. The samples
were then left to rest for 4-6 days in order for the chemo-
luminescence to decrease.
Scintillation counting was performed with a liquid scintil-
lation counter (14814 Win Spectral Guardian, Wallac Oy,
Turku, Finland). The specific activity of tritium was calcu-
lated for each sample. Two separate measurements were
performed, and the mean value of the two measurements
was used. Radioactivity is reported as the number of dis-
integrations per minute per ml (DPM/ml).
Statistics
All values are expressed as the mean ± 1 standard devia-
tion (SD). Comparisons between groups were made with
a two-tailed student's t-test, unless otherwise stated. To
quantify the physiological response in terms of a decrease
or increase in blood pressure, the area under the curve
(AUC) was calculated from the period of blood pressure
change (Figure 1). The end of the change was defined as
the point of time when the blood pressure had returned to
the pre-event value.
Results
Infusion of the shed blood surrogate resulted in an almost
immediate increase in the pulmonary pressure. In one
animal, the infusion led to total circulatory collapse
within 10 minutes due to acute right heart failure, despite
attempts to reverse the condition with epinephrine. This
animal was excluded from the analysis. Thus, the results
from 6 animals are presented.
Infusion of shed blood surrogate
The response of the arterial blood pressure after infusion
of shed blood was biphasic (Figure 2). Five of the 6 ani-
mals exhibited an initial decline in arterial blood pressure,
followed by an increase in pressure. This initial decrease
in systolic blood pressure was 53 ± 39 mmHg from base-
line, and was recorded after a mean of 158 ± 51 seconds.
The subsequent increase in systolic blood pressure from
pre-infusion baseline was 70 ± 69 mmHg. The physiolog-Journal of Cardiothoracic Surgery 2009, 4:48 http://www.cardiothoracicsurgery.org/content/4/1/48
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ical response measured as the AUC for the decreasing
period (Figure 1A) was significantly different from no
response (p < 0.05). The response expressed as the AUC
for the increase in arterial pressure did not reach signifi-
cance (p < 0.10) (Figure 1B).
Cardiac output declined concomitantly with the decrease
in arterial pressure (Figure 3), from 3.39 ± 0.68 to 1.59 ±
1.95 L/minute (p < 0,001) and was on average 53% from
base-line. The changes in systemic vascular resistance
(SVR) varied from animal to animal. In 2 animals there
was almost no response. In the other animals there were
both rapid increases and decreases in SVR during the ini-
tial period of hemodynamic instability, but no pattern
could be discerned (Figure 4).
The response of the pulmonary pressure after infusion of
the shed blood was biphasic (Figure 5). All animals
showed an initial increase in pulmonary pressure, fol-
lowed by a short decrease before a second rapid increase.
The initial increase in systolic pulmonary pressure from
baseline was 36 ± 10 mmHg (p < 0.05), which represents
a 156% increase in pulmonary systolic pressure. The sec-
ondary increase in pulmonary pressure was 47 ± 17
mmHg (p < 0.05) above baseline.
Pulmonary vascular resistance (PVR) increased signifi-
cantly in all animals (Figure 6). The mean increase in PVR
from 116 ± 67 dynes * s * cm-5 before infusion to 3446 ±
3676 dynes * s * cm-5 at the maximum PVR, and did not
return completely to baseline until after the infusion of
epinephrine and Ringer's lactate (Figure 6).
The central venous pressure increased and the left atrial
pressure decreased, in response to the infusion of the shed
blood surrogate (Figure 7).
Systolic and diastolic arterial blood pressure Figure 2
Systolic and diastolic arterial blood pressure. Mean 
values ± 1SD during the experiment. The first dashed line 
indicates the infusion of the shed blood surrogate. The sec-
ond dashed line indicates the infusion of epinephrine and 
Ringer's lactate.
Cardiac output Figure 3
Cardiac output. Mean values ± 1SD during the experiment. 
The first dashed line indicates the infusion of shed blood sur-
rogate. The second dashed line indicates the infusion of 
epinephrine and Ringer's lactate.
Peripheral vascular resistance Figure 4
Peripheral vascular resistance. Mean peripheral vascular 
resistance as determined from arterial blood pressure and 
cardiac output. The first dashed line indicates the infusion of 
shed blood surrogate. The second dashed line indicates the 
infusion of epinephrine and Ringer's lactate.Journal of Cardiothoracic Surgery 2009, 4:48 http://www.cardiothoracicsurgery.org/content/4/1/48
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Effects of the pharmacologically increased blood flow and 
pressure
After infusion of epinephrine and Ringer's lactate an
increase in arterial blood pressure ensued (Figure 2), as
shown by a significant increase in the AUC of the blood
pressure (p < 0.001). In addition, there was an increase in
cardiac output and SVR (Figures 3 and 4).
Pulmonary artery pressure and PVR increased transiently
after the infusion of epinephrine and Ringer's lactate.
Levels of radioactivity
The radioactivity levels in arterial blood increased after
the infusion of the shed blood surrogate (Figure 8). From
the baseline level of 2369 ± 1164 DPM/ml levels
increased to a peak of 3953 ± 1532 DPM/ml (p < 0.05), at
a mean time of 100 ± 50 seconds after infusion.
After the period of increased pulmonary blood flow and
pressure, the peak level was 4080 ± 981 DPM/ml at a
mean time of 390 ± 112 seconds, and was significantly
higher than the baseline value of 2369 ± 1164 DPM/ml (p
< 0.05).
Capnography
The deadspace (Vd/Vt) increased after infusion of the shed
blood surrogate (Figure 9), and reached its maximal levels
after 5, 15 or 30 minutes in 5 of the 6 animals. In one ani-
mal, no change in deadspace was observed. The mean
level of Vd/Vt before infusion of the shed blood was 0.49
± 0.06, compared to the highest levels after infusion 0.61
± 0.15 (p = 0.06).
Discussion
This study clearly demonstrates that a rapid intravenous
infusion of blood laden with lipid micro-particles has sig-
nificant hemodynamic effects in a porcine model, with
the most obvious finding being a considerable increase in
PVR and subsequent hemodynamic changes. Normally an
infusion of volume would yield and increased right ven-
Pulmonary vascular resistance Figure 6
Pulmonary vascular resistance. Mean pulmonary vascu-
lar resistance as determined from arterial blood pressure and 
cardiac output. The first dashed line indicates the infusion of 
shed blood surrogate. The second dashed line indicates the 
infusion of epinephrine and Ringer's lactate. The horizontal 
line denotes the baseline value calculated from the PVR dur-
ing the 10-minute resting period (prior to the shed blood 
surrogate infusion).
Central venous pressure and left atrial pressure Figure 7
Central venous pressure and left atrial pressure. Mean 
central venous pressure (dashed line) and left atrial pressure 
(solid line). The first dashed vertical line indicates the infusion 
of shed blood surrogate. The second dashed vertical line 
indicates the infusion of epinephrine and Ringer's lactate.
Systolic and diastolic pulmonary blood pressure Figure 5
Systolic and diastolic pulmonary blood pressure. Mean 
systolic and diastolic pulmonary blood pressure ± 1SD during 
the experiment. The first dashed line indicates the infusion of 
shed blood surrogate. The second dashed line indicates the 
infusion of epinephrine and Ringer's lactate.Journal of Cardiothoracic Surgery 2009, 4:48 http://www.cardiothoracicsurgery.org/content/4/1/48
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tricular filling and subsequent increase in cardiac out-
put[20]. The results also suggest that a substantial fraction
of the lipid micro-embolic load is trapped in the pulmo-
nary vasculature.
In addition to the obvious acute hemodynamic changes
directly after the infusion of shed blood, we also observed
hemodynamic effects of moderate duration. The acute
increase in PVR led to both right ventricle failure and
decreased cardiac output and, as a consequence, reduced
arterial blood pressure. These hemodynamic changes
could be attributed to the increase in pulmonary vascular
resistance.
The finding that infusing lipid material on the venous side
leads to negative hemodynamic consequences is not new.
The phenomenon has been studied extensively in studies
addressing adult respiratory distress syndrome and lipid
embolization in orthopedic trauma [15,16,21-24]. All
these studies, however, used models of macro-emboliza-
tion, where the infused lipid was normally a single bolus
of pure triolein, thus forming one or more large particles.
The abrupt hemodynamic changes found in our study was
similar to that in models of larger emboli [21,23]. In our
model, the intention was to simulate the situation of re-
infusing shed blood collected during surgery, which is
rich in lipid micro-emboli. A shed blood surrogate was
therefore produced, containing radiolabelled triolein,
which was agitated well to disperse the lipid into smaller
particles to mimic the clinical situation. In addition, the
infusion was passed through a 40 μm infusion filter to dis-
perse the particles even more. The particles would there-
fore theoretically be able to migrate deeply into the
capillaries of the lung.
The acute changes were obvious, with more than a 20-fold
increase in PVR. The mechanisms causing this increase
were not explored in this study. However, the increase was
transient in nature, and it could therefore be speculated
that several mechanisms play a role in this rapidly rising
PVR. Mechanical obstruction of capillaries can play a role
in the pathophysiology. A vascular wall response, leading
to a spasm, could also be involved; triolein itself may have
triggered such a spasm. Several authors have suggested
that liberated free fatty acids have direct local toxic effects,
which could promote a vasospasm [16,25]. Whatever
direct effects the triolein may have had, liberated free fatty
acids from the infused triolein could further have aggra-
vated the response. The acute response after the infusion
of the shed blood may well be multifactorial, and the dif-
ferent mechanisms considered here additive.
Changes of moderate duration were seen throughout the
3 hours of the test, but were not as striking. The PVR
remained slightly elevated until epinephrine and Ringer's
lactate were infused (Figure 5). Consequently, the pulmo-
nary artery pressure did not return to baseline at the same
time as the other parameters (Figure 6). Therefore, at least
one of the mechanisms behind the acute increase in PVR
Radioactivity Figure 8
Radioactivity. Mean amount of radioactivity in the carotid 
artery at each sampling time, as a measure of the amount of 
emboli passing through the pulmonary circulation. The first 
dashed line indicates the infusion of shed blood surrogate. 
The second dashed line indicates the infusion of epinephrine 
and Ringer's lactate. The horizontal line denotes the baseline 
value calculated from the two samples taken before infusion.
Ventilatory deadspace Figure 9
Ventilatory deadspace. Mean ventilatory deadspace esti-
mated from blood gas analysis and capnography. The first 
dashed line indicates the infusion of shed blood surrogate. 
The second dashed line indicates the infusion of epinephrine 
and Ringer's lactate.Journal of Cardiothoracic Surgery 2009, 4:48 http://www.cardiothoracicsurgery.org/content/4/1/48
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acts over a sustained period of time. It can not be deter-
mined from the results of this study which mechanism is
responsible for the delayed increase. However, mechani-
cal obstruction by the lipid emboli seems plausible.
The second part of the experiment involving a pharmaco-
logically induced increase in cardiac output and pulmo-
nary pressure, was carried out to study the effects of an
increased pressure gradient on the lipid emboli wedged in
the lungs. From the hemodynamic data, it can easily be
concluded that the response intended, in terms of hemo-
dynamic changes, was achieved. The PVR increased imme-
diately with an increase in both arterial and pulmonary
pressure. After this increase in PVR, there was a period of
decreased mean PVR, compared to levels before increased
blood pressure. The PVR then slowly increased once more.
These changes did not, however, reach statistical signifi-
cance, probably due to the small number of animals. Our
interpretation is that this increase in pressure either
wedged the particles further down into the capillaries or
forced some of them to pass out of the capillaries of the
lungs and into the systemic circulation.
Radiolabelled triolein has previously been used in a study
to determine the differential distribution of lipid emboli
after an arterial infusion [6]. The embolic load could eas-
ily be characterized using measurements of the radioactiv-
ity. The levels found in the present study, were low in
comparison with that study, and had a large variation.
However, a significant increase in PVR was observed
directly after the infusion, after which levels seemed to
return to baseline values (Figure 6). After the period of
induced increase in cardiac output, radioactivity levels
increased significantly, and thus some of the trapped
emboli must have been forced out of the lungs. Sikorski et
al concluded that 95% of triolein infused as macro-
emboli was trapped in the lungs [15]. Our findings sug-
gest that a high proportion of micro-emboli will also be
trapped in the lungs.
The shed blood surrogate, consisting of 200 ml saline, 200
ml blood and 5 ml triolein, was used to mimic the clinical
situation of retransfusing shed blood, collected from the
operating wound. The true composition of lipid particles
in such blood has not been studied thoroughly. In this
model, triolein was used, since it is the most common
triglyceride in adipose tissue and represents 50% of the
triglycerides[26]. A chemically more representative com-
position of triglycerides could affect results, but probably
only in terms of local toxic effects. It could be argued that
the effects of the transfusion of the surrogate are dose-
dependent, and that the amount of lipids given is experi-
mental and not representative of the clinical setting. How-
ever, experience from a previous study shows that the dose
used results in similar lipid droplet formation as seen on
the surface of shed mediastinal blood [6]. For the
moment, surprisingly few attempts have been made to
characterize the lipid content of shed blood, and compare
it with levels found in for instance orthopaedic surgery.
One study estimated the lipids concentration in shed
blood on average 0,4% in 400 ml blood[27]. Our model
contained 1% and would therefore represent blood with
lipid content in the high ranges. The shed blood surrogate
was infused as a short bolus, to achieve a distinct effect
with immediate response that could be correlated with
the intervention. This is seldom the practice in the clinical
setting. On the other hand, young healthy animals with
uncompromised lung and heart function were used,
which is seldom the case with patients, especially in car-
diac surgery patients, in which both the pulmonary and
right ventricle function may be compromised after cardi-
opulmonary bypass [28]. Therefore, the model is not
completely representative, and it could be argued that it
both underestimates and overestimates the response that
could be anticipated in patients.
Determinations of dead space revealed a transient
increase in the ventilatory deadspace directly after the
administration of the shed blood surrogate. However, val-
ues returned to normal after 45 minutes. Other models of
lipid macro-emboli have shown similar results [24]. How-
ever, in those studies the increase in deadspace lasted
throughout the entire experiments. Our findings suggest
that there is an acute phase in lipid micro-embolization
combining highly elevated PVR and an increase in dead
space, followed by a chronic phase with elevated PVR but
normalized deadspace.
There was considerable inter-animal variation in
response. All animals, with one exception, responded
with an increase in pulmonary blood pressure and a
decrease in arterial blood pressure. The animal that did
not show a decrease in systemic pressure still had an
increase in PVR. On the other hand, one animal went into
circulatory shock and could not be resuscitated with high
doses of epinephrine. This animal succumbed after 30
minutes, and was excluded from the analysis. Between the
extremes, the responses varied. There was a clear associa-
tion between the hemodynamic response and the change
in ventilatory deadspace. However, no association was
found between the hemodynamic response and the radi-
oactivity in arterial blood. The pathophysiology leading to
these different hemodynamic changes must surely be
multifactorial. Intrapulmonary shunting, an open
foramen ovale or, an individual susceptibility to lipid par-
ticles are some potential mechanisms.
In this study, we addressed issues of the potential danger
of lipid micro-emboli in the pulmonary circulation, that
have not been studied before. Our findings suggest partialJournal of Cardiothoracic Surgery 2009, 4:48 http://www.cardiothoracicsurgery.org/content/4/1/48
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lipid entrapment and occlusion in the capillaries of the
lungs. The hemodynamic effects of this entrapment are
transient, but strong, and are probably not directly trans-
ferable to the clinical setting, in which the infusion is
slower. However, since we found effects of moderate dura-
tion on PVR, it appears that the acute occlusion is only
one part of the pathophysiology, and that the delayed
increase in PVR is also of clinical relevance. In addition,
the constant passage of lipid particles through the lungs,
which could be augmented by an increase in pulmonary
artery pressure, subsequently led to arterial embolization
of lipid particles. The significance of lipid emboli in
organs such as the brain and the kidneys has been dis-
cussed previously, and the risk of serious organ dysfunc-
tion has been suggested [6,12-14]. The findings of this
study further lends support to the importance of using
strategies to eliminate lipid embolic material in shed
mediastinal blood, by using cell saver techniques and/or
filtration.
Conclusion
The findings of this study bring into question the appro-
priateness of transfusing autologous blood containing
lipid micro-emboli on the venous side. The suitability of
this procedure should be especially questioned when the
content of lipid micro-particles is high, when the volume
of blood is large, or when there already is a compromised
right ventricle or lung function.
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